{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T01:43:34Z","timestamp":1777081414263,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T00:00:00Z","timestamp":1713139200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006447","name":"University of Zurich","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006447","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Monit Comput"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The purpose of this in vitro study was to evaluate the impact of the vertical level of the stopcock connecting the infusion line to the central venous catheter on start-up fluid delivery in microinfusions.\u00a0Start-up fluid delivery was measured under standardized conditions with the syringe outlet and liquid flow sensors positioned at heart level (0\u00a0cm) and exposed to a simulated CVP of 10\u00a0mmHg at a set flow rate of 1\u00a0ml\/h. Flow and intraluminal pressures were measured with the infusion line connected to the stopcock primarily placed at vertical levels of 0\u00a0cm,\u2009+\u200930\u00a0cm and\u2009\u2212\u200930\u00a0cm or primarily placed at 0\u00a0cm and secondarily, after connecting the infusion line, displaced to\u2009+\u200930\u00a0cm and\u2009\u2212\u200930\u00a0cm. Start-up fluid delivery 10\u00a0s after opening the stopcock placed at zero level and after opening the stopcock primarily connected at zero level and secondary displaced to vertical levels of\u2009+\u200930\u00a0cm and \u2013 30\u00a0cm were similar (\u2212\u200910.52 [\u2212\u200913.85 to\u2009\u2212\u20097.19] \u00b5L;\u2009\u2212\u20098.84 [\u2212\u200912.34 to\u2009\u2212\u20095.33] \u00b5L and\u2009\u2212\u200911.19 [\u2212\u200913.71 to\u2009\u2212\u20098.67] \u00b5L (<jats:italic>p<\/jats:italic>\u2009=\u20090.469)). Fluid delivered at 360\u00a0s related to 65% (zero level), 71% (+\u200930\u00a0cm) and 67% (\u2212\u200930\u00a0cm) of calculated infusion volume (<jats:italic>p<\/jats:italic>\u2009=\u20090.395). Start-up fluid delivery with the stopcock primarily placed at\u2009+\u200930\u00a0cm and\u2009\u2212\u200930\u00a0cm resulted in large anterograde and retrograde fluid volumes of 34.39 [33.43 to 35.34] \u00b5L and\u2009\u2212\u200924.90 [\u2212\u200927.79 to\u2009\u2212\u200922.01] \u00b5L at 10\u00a0s, respectively (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Fluid delivered with the stopcock primarily placed at\u2009+\u200930\u00a0cm and\u2009\u2212\u200930\u00a0cm resulted in 140% and 35% of calculated volume at 360\u00a0s, respectively (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Syringe infusion pumps should ideally be connected to the stopcock positioned at heart level in order to minimize the amounts of anterograde and retrograde fluid volumes after opening of the stopcock.<\/jats:p>","DOI":"10.1007\/s10877-024-01156-z","type":"journal-article","created":{"date-parts":[[2024,4,15]],"date-time":"2024-04-15T07:01:50Z","timestamp":1713164510000},"page":"1209-1218","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Effect of vertical stopcock position on start-up fluid delivery in syringe pumps used for microinfusions"],"prefix":"10.1007","volume":"38","author":[{"given":"Markus","family":"Weiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro David","family":"Wendel-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate","family":"Grass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maren","family":"Kleine-Brueggeney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,4,15]]},"reference":[{"key":"1156_CR1","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.bja.2020.06.041","volume":"125","author":"L Poiroux","year":"2020","unstructured":"Poiroux L, Le Roy C, Ramelet AS, et al. Minimising haemodynamic lability during changeover of syringes infusing norepinephrine in adult critical care patients: a multicentre randomised controlled trial. Br J Anaesth. 2020;125:622\u20138.","journal-title":"Br J Anaesth"},{"key":"1156_CR2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1017\/S1047951117002232","volume":"28","author":"BJ Achuff","year":"2018","unstructured":"Achuff BJ, Achuff JC, Park HH, Moffett B, Acosta S, Rusin CG, Checchia PA. Epinephrine syringe exchange events in a paediatric cardiovascular ICU: analysing the storm. Cardiol Young. 2018;28:409\u201315.","journal-title":"Cardiol Young"},{"key":"1156_CR3","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0964-3397(04)00017-5","volume":"20","author":"JC Trim","year":"2004","unstructured":"Trim JC, Roe J. Practical considerations in the administration of intravenous vasoactive drugs in the critical care setting. Intensive Crit Care Nurs. 2004;20:153\u201360.","journal-title":"Intensive Crit Care Nurs"},{"key":"1156_CR4","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1517\/17425247.2013.785519","volume":"10","author":"RA Peterfreund","year":"2013","unstructured":"Peterfreund RA, Philip JH. Critical parameters in drug delivery by intravenous infusion. Expert Opin Drug Deliv. 2013;10:1095\u2013108.","journal-title":"Expert Opin Drug Deliv"},{"key":"1156_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bja.2019.10.007","volume":"124","author":"M Baeckert","year":"2020","unstructured":"Baeckert M, Batliner M, Grass B, et al. Performance of modern syringe infusion pump assemblies at low infusion rates in the perioperative setting. Br J Anaesth. 2020;124:173\u201382.","journal-title":"Br J Anaesth"},{"key":"1156_CR6","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1007\/s10877-021-00790-1","volume":"36","author":"LE Gibson","year":"2022","unstructured":"Gibson LE, Knudsen AS, Arney D, Deng H, Sims NM, Peterfreund RA. Lag times to steady state drug delivery by continuous intravenous infusion: direct comparison of peristaltic and syringe pump performance identifies contributions from infusion system dead volume and pump startup characteristics. J Clin Monit Comput. 2022;36:1489\u201398.","journal-title":"J Clin Monit Comput"},{"key":"1156_CR7","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1177\/1129729820909024","volume":"21","author":"S Elli","year":"2020","unstructured":"Elli S, Mattiussi E, Bambi S, et al. Changing the syringe pump: a challenging procedure in critically ill patients. J Vasc Access. 2020;21:868\u201374.","journal-title":"J Vasc Access"},{"key":"1156_CR8","doi-asserted-by":"publisher","first-page":"e463","DOI":"10.1016\/j.bja.2020.09.005","volume":"125","author":"V Russotto","year":"2020","unstructured":"Russotto V, Elli S, Rona R, Lucchini A. Effect of central venous pressure on back-flow and bolus events during vasopressor syringe changeover. Br J Anaesth. 2020;125:e463\u2013544.","journal-title":"Br J Anaesth"},{"issue":"33","key":"1156_CR9","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/pan.14717","volume":"2023","author":"M Weiss","year":"2023","unstructured":"Weiss M, Wendel-Garcia PD, Cannizzaro V, Buehler PK, Kleine-Brueggeney M. Effect of central venous pressure on fluid delivery during start-up of syringe infusion pumps for microinfusion. Paediatr Anaesth. 2023;2023(33):837\u201343.","journal-title":"Paediatr Anaesth"},{"key":"1156_CR10","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1111\/pan.14750","volume":"33","author":"M Weiss","year":"2023","unstructured":"Weiss M, Wendel-Garcia PD, Grass B, Buehler PK, Kleine-Brueggeney M. Effect of vertical pump position on start-up fluid delivery of syringe pumps used for microinfusion. Paediatr Anaesth. 2023;33:1099\u2013107.","journal-title":"Paediatr Anaesth"},{"key":"1156_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s10877-023-01068-4","volume":"38","author":"M Weiss","year":"2024","unstructured":"Weiss M, Wendel-Garcia PD, Cannizzaro V, Buehler PK. Kleine-Brueggeney M Evaluation of the venting principle to reduce start-up delays in syringe infusion pumps used for microinfusions. J Clin Monit Comput. 2024;38:213\u201320.","journal-title":"J Clin Monit Comput"},{"key":"1156_CR12","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s001340051246","volume":"26","author":"M Weiss","year":"2000","unstructured":"Weiss M, B\u00e4nziger O, Neff T, Fanconi S. Influence of infusion line compliance on drug delivery rate during acute line loop formation. Intensive Care Med. 2000;26:776\u20139.","journal-title":"Intensive Care Med"},{"key":"1156_CR13","doi-asserted-by":"crossref","unstructured":"Weiss M, Wendel-Garcia PD, Cannizzaro V, Grass B, Buehler PK, Kleine-Brueggeney M. Pressure-adjusted venting eliminates start-up delays and compensates for vertical position of syringe infusion pumps used for microinfusion. J Clin Monit Comput. 2023. Online ahead of print.","DOI":"10.1007\/s10877-023-01101-6"},{"key":"1156_CR14","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1046\/j.1365-2044.2000.01550.x","volume":"55","author":"M Weiss","year":"2000","unstructured":"Weiss M, Fischer J, Neff T, Baenziger O. The effects of syringe plunger design on drug delivery during vertical displacement of syringe pumps. Anaesthesia. 2000;55:1094\u20138.","journal-title":"Anaesthesia"},{"key":"1156_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s001340000784","volume":"27","author":"TA Neff","year":"2001","unstructured":"Neff TA, Fischer JE, Schulz G, Baenziger O, Weiss M. Infusion pump performance with vertical displacement: effect of syringe pump and assembly type. Intensive Care Med. 2001;27:287\u201391.","journal-title":"Intensive Care Med"},{"key":"1156_CR16","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/PCC.0b013e3181c31848","volume":"11","author":"N Schmidt","year":"2010","unstructured":"Schmidt N, Saez C, Seri I, Maturana A. Impact of syringe size on the performance of infusion pumps at low flow rates. Pediatr Crit Care Med. 2010;11:282\u20136.","journal-title":"Pediatr Crit Care Med"},{"key":"1156_CR17","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s10877-023-00973-y","volume":"37","author":"KY Hong","year":"2023","unstructured":"Hong KY, Lee EK, Kim Y, Choi DC, Min JJ. Effects of infusion tubing line lengths and syringe sizes on infusion system compliance: an experimental study using a syringe-type infusion pump at low flow rate. J Clin Monit Comput. 2023;37:1379\u201386.","journal-title":"J Clin Monit Comput"},{"key":"1156_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ejps.2016.07.019","volume":"93","author":"RA Snijder","year":"2016","unstructured":"Snijder RA, Egberts TC, Lucas P, Lemmers PM, van Bel F, Timmerman AM. Dosing errors in preterm neonates due to flow rate variability in multi-infusion syringe pump setups: an in vitro spectrophotometry study. Eur J Pharm Sci. 2016;93:56\u201363.","journal-title":"Eur J Pharm Sci"},{"key":"1156_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/aas.12439","volume":"59","author":"S Genay","year":"2015","unstructured":"Genay S, D\u00e9caudin B, Scoccia S, Barth\u00e9l\u00e9my C, Debaene B, Lebuffe G, Odou P. An in vitro evaluation of infusion methods using a syringe pump to improve noradrenaline administration. Acta Anaesthesiol Scand. 2015;59:197\u2013204.","journal-title":"Acta Anaesthesiol Scand"}],"container-title":["Journal of Clinical Monitoring and Computing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10877-024-01156-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10877-024-01156-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10877-024-01156-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T09:05:03Z","timestamp":1727341503000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10877-024-01156-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,15]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["1156"],"URL":"https:\/\/doi.org\/10.1007\/s10877-024-01156-z","relation":{},"ISSN":["1387-1307","1573-2614"],"issn-type":[{"value":"1387-1307","type":"print"},{"value":"1573-2614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,15]]},"assertion":[{"value":"30 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics committee approval"}},{"value":"MW serves as a consultant for medical device industries and has received consultant honoraria from BD. MW is cofounder of Silberspross GmbH Zurich, Switzerland, an innovation company advancing safety of intravenous drug therapy holding a patent on a new infusion access port. All other authors have no relevant financial or non-financial interests to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}